2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
10
Colonic Neoplasms
9
Prostatic Neoplasms
8
Colorectal Neoplasms
6
Neoplasms
5
Multiple Myeloma
4
Uterine Cervical Neoplasms
3
Stomach Neoplasms
3
Smoldering Multiple Myeloma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Adenomatous Polyposis Coli
3
Uterine Cervical Dysplasia
2
Radiodermatitis
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Paclitaxel
95
Carboplatin
76
pembrolizumab
72
Cisplatin
28
Bevacizumab
27
Surveys and Questionnaires
23
Radiotherapy
22
Letrozole
22
Doxorubicin
21
Megestrol Acetate
20
olaparib
19
lenvatinib
19
Taxes
17
Specimen Handling
17
Docetaxel
17
Nivolumab
16
Magnetic Resonance Spectroscopy
16
dostarlimab
15
Metformin
15
Observation
13
Gemcitabine
13
Blood Specimen Collection
13
Biopsy
13
durvalumab
12
Medroxyprogesterone Acetate
12
Trastuzumab
11
Indocyanine Green
11
Fulvestrant
11
temsirolimus
10
abemaciclib
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Curcumin
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled